| Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem … I Tzannou, A Papadopoulou, S Naik, K Leung, CA Martinez, CA Ramos, ... Journal of Clinical Oncology 35 (31), 3547, 2017 | 450 | 2017 |
| Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells T Shum, B Omer, H Tashiro, RL Kruse, DL Wagner, K Parikh, Z Yi, ... Cancer discovery 7 (11), 1238-1247, 2017 | 265 | 2017 |
| NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors R Parihar, C Rivas, M Huynh, B Omer, N Lapteva, LS Metelitsa, ... Cancer immunology research 7 (3), 363-375, 2019 | 213 | 2019 |
| Treatment of acute myeloid leukemia with T cells expressing chimeric antigen receptors directed to C-type lectin-like molecule 1 H Tashiro, T Sauer, T Shum, K Parikh, M Mamonkin, B Omer, RH Rouce, ... Molecular Therapy 25 (9), 2202-2213, 2017 | 148 | 2017 |
| CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity T Sauer, K Parikh, S Sharma, B Omer, D Sedloev, Q Chen, L Angenendt, ... Blood, The Journal of the American Society of Hematology 138 (4), 318-330, 2021 | 145 | 2021 |
| Vaccination targeting native receptors to enhance the function and proliferation of chimeric antigen receptor (CAR)-modified T cells M Tanaka, H Tashiro, B Omer, N Lapteva, J Ando, M Ngo, B Mehta, ... Clinical Cancer Research 23 (14), 3499-3509, 2017 | 93 | 2017 |
| Comprehensive approach for identifying the T cell subset origin of CD3 and CD28 antibody–activated chimeric antigen receptor–modified T cells M Schmueck-Henneresse, B Omer, T Shum, H Tashiro, M Mamonkin, ... The Journal of Immunology 199 (1), 348-362, 2017 | 54 | 2017 |
| Posoleucel, an allogeneic, off-the-shelf multivirus-specific T-cell therapy, for the treatment of refractory viral infections in the post-HCT setting T Pfeiffer, I Tzannou, M Wu, C Ramos, G Sasa, C Martinez, P Lulla, ... Clinical Cancer Research 29 (2), 324-330, 2023 | 52 | 2023 |
| T-cell receptor stimulation enhances the expansion and function of CD19 chimeric antigen receptor–expressing T cells N Lapteva, M Gilbert, I Diaconu, LA Rollins, M Al-Sabbagh, S Naik, ... Clinical Cancer Research 25 (24), 7340-7350, 2019 | 49 | 2019 |
| Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy … J Sun, LE Huye, N Lapteva, M Mamonkin, M Hiregange, B Ballard, ... Journal for immunotherapy of cancer 3 (1), 1-17, 2015 | 45 | 2015 |
| “Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients I Tzannou, A Watanabe, S Naik, R Daum, M Kuvalekar, KS Leung, ... Blood advances 3 (17), 2571-2580, 2019 | 43 | 2019 |
| A new method for reactivating and expanding T cells specific for Rhizopus oryzae P Castillo, KE Wright, DP Kontoyiannis, T Walsh, S Patel, E Chorvinsky, ... Molecular Therapy-Methods & Clinical Development 9, 305-312, 2018 | 36 | 2018 |
| Patterns of subsequent malignancies after H odgkin lymphoma in children and adults B Omer, NS Kadan‐Lottick, KB Roberts, R Wang, C Demsky, GM Kupfer, ... British journal of haematology 158 (5), 615-625, 2012 | 36 | 2012 |
| High incidence of autoimmune disease after hematopoietic stem cell transplantation for chronic granulomatous disease AD Yanir, IC Hanson, WT Shearer, LM Noroski, LR Forbes, FO Seeborg, ... Biology of Blood and Marrow Transplantation 24 (8), 1643-1650, 2018 | 30 | 2018 |
| Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs DHM Steffin, IN Muhsen, LQC Hill, CA Ramos, N Ahmed, M Hegde, ... Blood, The Journal of the American Society of Hematology 140 (1), 16-24, 2022 | 25 | 2022 |
| Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives—A Single-Center Experience, 2008 … AD Yanir, CA Martinez, G Sasa, K Leung, S Gottschalk, B Omer, N Ahmed, ... Biology of Blood and Marrow Transplantation 24 (7), 1424-1431, 2018 | 22 | 2018 |
| A Costimulatory CAR Improves TCR-based Cancer Immunotherapy B Omer, MG Cardenas, T Pfeiffer, R Daum, M Huynh, S Sharma, ... Cancer immunology research 10 (4), 512-524, 2022 | 21 | 2022 |
| Outcomes after allogeneic transplant in patients with Wiskott-Aldrich syndrome A Ngwube, IC Hanson, J Orange, NL Rider, F Seeborg, W Shearer, ... Biology of Blood and Marrow Transplantation 24 (3), 537-541, 2018 | 21 | 2018 |
| Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL S Naik, S Vasileiou, I Tzannou, M Kuvalekar, A Watanabe, C Robertson, ... Blood, The Journal of the American Society of Hematology 139 (17), 2706-2711, 2022 | 20 | 2022 |
| Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients S Naik, CA Martinez, B Omer, G Sasa, K Yassine, CE Allen, K Kamdar, ... Blood advances 3 (18), 2689-2695, 2019 | 17 | 2019 |
Cliona RooneyBaylor College of MedicineGeverifieerd e-mailadres voor texaschildrens.org
